Whalegun
Home

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q4 2022 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q4 2022
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
23/01/14

$460K on lobbying in 2022

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Acadia Pharmaceuticals's other lobbying reports

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q4 2022 · Health Issues, Medicare | Whalegun